| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SYKStryker Corporation | 136.07B | 355.82 | 45.85 | 10.23% | 12.07% | 13.51% | 2.56% | 0.68 |
| SNNSmith & Nephew plc | 13.54B | 31.90 | 33.94 | 4.7% | 6.88% | 14.44% | 4.48% | 0.63 |
| ZBHZimmer Biomet Holdings, Inc. | 17.51B | 88.34 | 19.94 | 3.85% | 10.05% | 6.31% | 6.53% | 0.50 |
| CNMDCONMED Corporation | 1.24B | 40.03 | 9.40 | 5% | 4.75% | 6.35% | 12.41% | 0.94 |
| DHAIDIH Holding US, Inc. | 6.7K | 0.00 | -0.00 | -2.5% | -13.8% | |||
| LFWDLifeward Ltd. | 12.57M | 0.69 | -0.21 | 85.24% | -121.82% | -233.98% | 0.05 | |
| ANIKAnika Therapeutics, Inc. | 137.72M | 9.55 | -2.49 | -0.73% | -40.83% | -22.5% | 0.17 | |
| SNWVSANUWAVE Health, Inc. | 245.02M | 28.57 | -4.06 | 59.99% | -17.06% | 0.8% |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 5.87M | 7.75M | 6.54M | 4.87M | 4.39M | 5.97M | 5.51M | 13.85M | 25.66M |
| Revenue Growth % | - | 0.32% | -0.16% | -0.26% | -0.1% | 0.36% | -0.08% | 1.51% | 0.85% |
| Cost of Goods Sold | 5.13M | 4.65M | 3.72M | 2.15M | 2.2M | 3.06M | 3.61M | 9.4M | 17.45M |
| COGS % of Revenue | 0.87% | 0.6% | 0.57% | 0.44% | 0.5% | 0.51% | 0.65% | 0.68% | 0.68% |
| Gross Profit | 736K | 3.1M | 2.83M | 2.73M | 2.19M | 2.9M | 1.91M | 4.45M | 8.22M |
| Gross Margin % | 0.13% | 0.4% | 0.43% | 0.56% | 0.5% | 0.49% | 0.35% | 0.32% | 0.32% |
| Gross Profit Growth % | - | 3.21% | -0.09% | -0.04% | -0.2% | 0.33% | -0.34% | 1.34% | 0.85% |
| Operating Expenses | 31.18M | 25.09M | 22.04M | 16.77M | 14.19M | 15.56M | 21.01M | 28.07M | 27.77M |
| OpEx % of Revenue | 5.31% | 3.24% | 3.37% | 3.44% | 3.23% | 2.61% | 3.81% | 2.03% | 1.08% |
| Selling, General & Admin | 22.15M | 19.05M | 14.69M | 11.43M | 10.73M | 12.62M | 16.98M | 23.92M | 23.14M |
| SG&A % of Revenue | 3.77% | 2.46% | 2.24% | 2.34% | 2.44% | 2.12% | 3.08% | 1.73% | 0.9% |
| Research & Development | 9.03M | 6.04M | 7.35M | 5.35M | 3.46M | 2.94M | 4.03M | 4.15M | 4.63M |
| R&D % of Revenue | 1.54% | 0.78% | 1.12% | 1.1% | 0.79% | 0.49% | 0.73% | 0.3% | 0.18% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -30.44M | -21.99M | -19.21M | -14.05M | -12M | -12.65M | -19.1M | -23.61M | -19.55M |
| Operating Margin % | -5.19% | -2.84% | -2.94% | -2.88% | -2.73% | -2.12% | -3.47% | -1.7% | -0.76% |
| Operating Income Growth % | - | 0.28% | 0.13% | 0.27% | 0.15% | -0.05% | -0.51% | -0.24% | 0.17% |
| EBITDA | -29.75M | -21.35M | -18.75M | -13.73M | -11.72M | -12.39M | -18.9M | -21.77M | -15.71M |
| EBITDA Margin % | -5.07% | -2.75% | -2.86% | -2.82% | -2.67% | -2.08% | -3.43% | -1.57% | -0.61% |
| EBITDA Growth % | - | 0.28% | 0.12% | 0.27% | 0.15% | -0.06% | -0.53% | -0.15% | 0.28% |
| D&A (Non-Cash Add-back) | 696K | 642K | 463K | 321K | 285K | 266K | 202K | 1.85M | 3.84M |
| EBIT | -30.52M | -22.15M | -19.28M | -14.04M | -12.02M | -12.62M | -19.08M | -23.61M | -28.77M |
| Net Interest Income | -2.01M | -2.48M | -2.42M | -1.53M | -930K | -25K | -22K | 1.33M | 515K |
| Interest Income | 0 | 0 | 0 | 0 | - | 0 | 0 | 1.35M | 643K |
| Interest Expense | 2.01M | 2.48M | 2.42M | 1.53M | 930K | 25K | 22K | 20K | 128K |
| Other Income/Expense | -2.06M | -2.61M | -2.47M | -1.5M | -921K | 13K | 0 | 1.47M | -9.35M |
| Pretax Income | -32.5M | -24.6M | -21.68M | -15.54M | -12.93M | -12.64M | -19.1M | -22.14M | -28.9M |
| Pretax Margin % | -5.54% | -3.17% | -3.31% | -3.19% | -2.94% | -2.12% | -3.47% | -1.6% | -1.13% |
| Income Tax | 3K | 119K | -5K | 7K | 51K | 94K | 467K | -12K | 43K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1.01% | 1.02% | 1% | 1% |
| Net Income | -32.5M | -24.72M | -21.68M | -15.55M | -12.98M | -12.74M | -19.57M | -22.13M | -28.94M |
| Net Margin % | -5.54% | -3.19% | -3.31% | -3.19% | -2.95% | -2.13% | -3.55% | -1.6% | -1.13% |
| Net Income Growth % | - | 0.24% | 0.12% | 0.28% | 0.17% | 0.02% | -0.54% | -0.13% | -0.31% |
| Net Income (Continuing) | -32.5M | -24.72M | -21.68M | -15.55M | -12.98M | -12.74M | -19.57M | -22.13M | -28.94M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -431.63 | -213.98 | -103.04 | -18.90 | -5.74 | -1.86 | -2.20 | -2.59 | -3.33 |
| EPS Growth % | - | 0.5% | 0.52% | 0.82% | 0.7% | 0.68% | -0.18% | -0.18% | -0.29% |
| EPS (Basic) | -431.63 | -213.98 | -103.04 | -18.90 | -5.74 | -1.86 | -2.20 | -2.59 | -3.33 |
| Diluted Shares Outstanding | 75.3K | 115.51K | 210.36K | 823.33K | 2.25M | 6.85M | 8.91M | 8.53M | 8.69M |
| Basic Shares Outstanding | 75.3K | 115.51K | 210.36K | 823.33K | 2.25M | 6.85M | 8.91M | 8.53M | 8.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 29.49M | 20.94M | 13.24M | 21.07M | 25.25M | 92.52M | 72.51M | 39.22M | 21.29M |
| Cash & Short-Term Investments | 23.68M | 14.57M | 9.55M | 16.25M | 20.35M | 88.34M | 67.9M | 28.08M | 6.94M |
| Cash Only | 23.68M | 14.57M | 9.55M | 16.25M | 20.35M | 88.34M | 67.9M | 28.08M | 6.94M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.25M | 1.1M | 758K | 794K | 684K | 585K | 1.04M | 3.12M | 6M |
| Days Sales Outstanding | 77.99 | 51.93 | 42.27 | 59.47 | 56.83 | 35.79 | 68.62 | 82.2 | 85.39 |
| Inventory | 3.26M | 4.28M | 2.61M | 3.37M | 3.54M | 2.99M | 2.93M | 5.65M | 6.72M |
| Days Inventory Outstanding | 232.1 | 335.58 | 256.19 | 572.75 | 586.58 | 356.18 | 296.47 | 219.48 | 140.65 |
| Other Current Assets | 936K | 649K | 167K | 339K | 120K | 270K | 233K | 1M | 578K |
| Total Non-Current Assets | 2.28M | 1.93M | 1.73M | 3.3M | 2.82M | 2.23M | 1.73M | 23.97M | 9.19M |
| Property, Plant & Equipment | 1.26M | 840K | 626K | 2.24M | 1.79M | 1.17M | 1.03M | 3.12M | 1.42M |
| Fixed Asset Turnover | 4.67x | 9.23x | 10.46x | 2.18x | 2.46x | 5.12x | 5.34x | 4.44x | 18.14x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.54M | 7.54M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.53M | 0 |
| Long-Term Investments | 0 | 856K | 801K | 739K | 704K | 713K | 659K | 709K | 362K |
| Other Non-Current Assets | 1.02M | 229K | 298K | 322K | 329K | 351K | 35K | 75K | -122K |
| Total Assets | 31.76M | 22.86M | 14.96M | 24.37M | 28.07M | 94.75M | 74.24M | 63.19M | 30.49M |
| Asset Turnover | 0.18x | 0.34x | 0.44x | 0.20x | 0.16x | 0.06x | 0.07x | 0.22x | 0.84x |
| Asset Growth % | - | -0.28% | -0.35% | 0.63% | 0.15% | 2.38% | -0.22% | -0.15% | -0.52% |
| Total Current Liabilities | 12.4M | 9.73M | 5.38M | 10.17M | 4.67M | 4.04M | 4.78M | 11.79M | 10.22M |
| Accounts Payable | 3.42M | 1.81M | 2.33M | 2.7M | 2.27M | 1.38M | 1.95M | 5.07M | 5.02M |
| Days Payables Outstanding | 243.48 | 142.09 | 228.42 | 458.67 | 375.6 | 164.92 | 197.38 | 196.81 | 105.06 |
| Short-Term Debt | 7.5M | 6.44M | 1.72M | 6.08M | 0 | 0 | 0 | 0 | 858K |
| Deferred Revenue (Current) | 54K | 123K | 237K | 323K | 441K | 316K | 301K | 1000K | 1000K |
| Other Current Liabilities | 406K | 480K | 445K | 402K | 432K | 555K | 685K | 1.89M | 1.76M |
| Current Ratio | 2.38x | 2.15x | 2.46x | 2.07x | 5.41x | 22.91x | 15.16x | 3.33x | 2.08x |
| Quick Ratio | 2.12x | 1.71x | 1.97x | 1.74x | 4.65x | 22.17x | 14.55x | 2.85x | 1.43x |
| Cash Conversion Cycle | 66.61 | 245.41 | 70.04 | 173.55 | 267.82 | 227.05 | 167.71 | 104.87 | 120.98 |
| Total Non-Current Liabilities | 11.11M | 9.43M | 7.63M | 3.42M | 1.63M | 1.33M | 1.29M | 4.89M | 1.41M |
| Long-Term Debt | 10.52M | 8.91M | 6.96M | 1.53M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.31M | 923K | 418K | 333K | 607K | 22K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 303K | 256K | 239K | 61K | 35K | 45K | 66K | 2.77M | 67K |
| Total Liabilities | 23.5M | 19.16M | 13.02M | 13.59M | 6.29M | 5.37M | 6.07M | 16.68M | 11.64M |
| Total Debt | 18.01M | 15.35M | 8.69M | 8.92M | 1.58M | 1.06M | 897K | 1.9M | 880K |
| Net Debt | -5.67M | 785K | -859K | -7.34M | -18.77M | -87.28M | -67M | -26.18M | -6.06M |
| Debt / Equity | 2.18x | 4.14x | 4.47x | 0.83x | 0.07x | 0.01x | 0.01x | 0.04x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -15.14x | -8.86x | -7.93x | -9.18x | -12.91x | -506.20x | -868.27x | -1180.60x | -152.76x |
| Total Equity | 8.26M | 3.71M | 1.95M | 10.78M | 21.77M | 89.38M | 68.17M | 46.51M | 18.85M |
| Equity Growth % | - | -0.55% | -0.48% | 4.54% | 1.02% | 3.11% | -0.24% | -0.32% | -0.59% |
| Book Value per Share | 109.69 | 32.09 | 9.25 | 13.09 | 9.67 | 13.05 | 7.65 | 5.45 | 2.17 |
| Total Shareholders' Equity | 8.26M | 3.71M | 1.95M | 10.78M | 21.77M | 89.38M | 68.17M | 46.51M | 18.85M |
| Common Stock | 45K | 84K | 193K | 504K | 1.83M | 4.66M | 4.49M | 4.49M | 4.59M |
| Retained Earnings | -106.49M | -131.22M | -152.92M | -168.47M | -181.44M | -194.18M | -213.75M | -235.88M | -264.82M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | -2.43M | -3.2M | -3.2M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -27.54M | -22.5M | -14.77M | -14.81M | -12.59M | -11.47M | -17.89M | -20.67M | -21.72M |
| Operating CF Margin % | -4.69% | -2.9% | -2.26% | -3.04% | -2.87% | -1.92% | -3.25% | -1.49% | -0.85% |
| Operating CF Growth % | - | 0.18% | 0.34% | -0% | 0.15% | 0.09% | -0.56% | -0.16% | -0.05% |
| Net Income | -32.5M | -24.72M | -21.68M | -15.55M | -12.98M | -12.74M | -19.57M | -22.13M | -28.94M |
| Depreciation & Amortization | 696K | 642K | 463K | 321K | 285K | 266K | 202K | 1.85M | 3.84M |
| Stock-Based Compensation | 0 | 0 | 0 | 1.11M | 749K | 833K | 993K | 1.33M | 1.28M |
| Deferred Taxes | -5K | 73K | -107K | -57K | -44K | -29K | 316K | -45K | 0 |
| Other Non-Cash Items | 4.53M | 7.42M | 2.3M | 0 | -392K | 0 | 79K | -326K | 7.08M |
| Working Capital Changes | 210K | -2.59M | 2.96M | -636K | -211K | 197K | 88K | -1.34M | -4.97M |
| Change in Receivables | 892K | 151K | 322K | -36K | 110K | 99K | -408K | -311K | -2.88M |
| Change in Inventory | -911K | -582K | 1.4M | -1.22M | -469K | 432K | -117K | -277K | -920K |
| Change in Payables | 950K | -1.61M | 492K | 370K | -506K | -884K | 566K | 1.04M | -47K |
| Cash from Investing | -437K | -21K | -13K | -22K | -73K | -47K | -25K | -18.15M | 0 |
| Capital Expenditures | -452K | -21K | -13K | -22K | -73K | -47K | -25K | -81K | 0 |
| CapEx % of Revenue | 0.08% | 0% | 0% | 0% | 0.02% | 0.01% | 0% | 0.01% | - |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 33.78M | 13.41M | 9.71M | 21.48M | 16.72M | 79.51M | -2.5M | -992K | 0 |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | -501K | 38K | 0 | 11.39M | 4.22M | 15.06M | 0 | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -27.99M | -22.52M | -14.79M | -14.84M | -12.66M | -11.52M | -17.92M | -20.75M | -21.72M |
| FCF Margin % | -4.77% | -2.9% | -2.26% | -3.04% | -2.88% | -1.93% | -3.25% | -1.5% | -0.85% |
| FCF Growth % | - | 0.2% | 0.34% | -0% | 0.15% | 0.09% | -0.56% | -0.16% | -0.05% |
| FCF per Share | -371.69 | -194.95 | -70.29 | -18.02 | -5.62 | -1.68 | -2.01 | -2.43 | -2.50 |
| FCF Conversion (FCF/Net Income) | 0.85x | 0.91x | 0.68x | 0.95x | 0.97x | 0.90x | 0.91x | 0.93x | 0.75x |
| Interest Paid | 1.3M | 2.3M | 1.5M | 1.5M | 862K | 0 | 0 | 1.34M | 0 |
| Taxes Paid | 45K | 21K | 25K | 21K | 13K | 40K | 113K | 126K | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -393.5% | -413.09% | -766.99% | -244.42% | -79.72% | -22.92% | -24.84% | -38.6% | -88.56% |
| Return on Invested Capital (ROIC) | -879.8% | -465.47% | -516.69% | -465.17% | -279.12% | -371.33% | -875.97% | -164.77% | -88.57% |
| Gross Margin | 12.54% | 40% | 43.16% | 55.94% | 49.83% | 48.66% | 34.57% | 32.14% | 32.02% |
| Net Margin | -553.81% | -318.81% | -331.17% | -319.13% | -295.38% | -213.48% | -355.09% | -159.76% | -112.78% |
| Debt / Equity | 2.18x | 4.14x | 4.47x | 0.83x | 0.07x | 0.01x | 0.01x | 0.04x | 0.05x |
| Interest Coverage | -15.14x | -8.86x | -7.93x | -9.18x | -12.91x | -506.20x | -868.27x | -1180.60x | -152.76x |
| FCF Conversion | 0.85x | 0.91x | 0.68x | 0.95x | 0.97x | 0.90x | 0.91x | 0.93x | 0.75x |
| Revenue Growth | - | 32.1% | -15.58% | -25.55% | -9.85% | 35.81% | -7.63% | 151.39% | 85.24% |
| 2024 | |
|---|---|
| Product | 19.92M |
| Product Growth | - |
| 2024 | |
|---|---|
| United States | 14.43M |
| United States Growth | - |
| Europe | 9.55M |
| Europe Growth | - |
| Rest Of World | 867K |
| Rest Of World Growth | - |
| Asia Pacific | 825K |
| Asia Pacific Growth | - |
Lifeward Ltd. (LFWD) reported $24.5M in revenue for fiscal year 2024. This represents a 317% increase from $5.9M in 2016.
Lifeward Ltd. (LFWD) grew revenue by 85.2% over the past year. This is strong growth.
Lifeward Ltd. (LFWD) reported a net loss of $29.8M for fiscal year 2024.
Lifeward Ltd. (LFWD) has a return on equity (ROE) of -88.6%. Negative ROE indicates the company is unprofitable.
Lifeward Ltd. (LFWD) had negative free cash flow of $17.2M in fiscal year 2024, likely due to heavy capital investments.